Attenuation of rodent lung ischemia-reperfusion injury by sphingosine 1-phosphate

Journal of Organ Dysfunction

Volumn 4, Issue 2, 2008, Pages 106-114

  Moreno Vinasco, Liliana ^a   Jacobson, Jeffrey R ^a   Bonde, Pramod ^b   Sammani, Saad ^a   Mirzapoiazova, Tamara ^a   Vigneswaran, Wickii T ^c   Garcia, Joe G N ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Graft failure; Perfusate; Sphingosine 1 phosphate; Vascular permeability

Indexed keywords

ALBUMIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MYELOPEROXIDASE; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HISTOPATHOLOGY; INFLAMMATION; ISCHEMIA; LUNG EDEMA; LUNG GRAFT REJECTION; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; REPERFUSION INJURY; STATISTICAL ANALYSIS;

ANIMALIA; RATTUS; RODENTIA;

EID: 45849100184     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060701505289     Document Type: Article

References (42)

1. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-5.
2. De Perrot M, Waddell TK, Chamberlain D, Hutcheon M, Keshavjee S. De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant 2003;22:698-700.
3. Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 2005;24:1468-82.
4. Carter YM, Davis RD. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 2006;27:501-7.
5. Ng CS, Wan S, Arifi AA, Yim AP. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 2006;36:205-14.
6. Knoop C, Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 2006;27:521-33.
7. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-55.
8. Fisher AJ, Donnelly SC, Pritchard G, Dark JH, Corris PA. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 2004;59:434-7.
9. Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994;58:1158-62.
10. Dudek SM, Jacobson JR, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279:24692-700.
11. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701.
12. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 2004;170:987-93.
13. Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004;169:1245-51.
14. Rosen H, Liao J. Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr Opin Chem Biol 2003;7:461-8.
15. Yatomi Y, Yamamura S, Hisano N, Nakahara K, Igarashi Y, Ozaki Y. Sphingosine 1-phosphate breakdown in platelets. J Biochem (Tokyo) 2004;136:495-502.
16. Schaphorst KL, Chiang E, Jacobs KN, et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 2003;285:/L258-67.
17. Yatomi Y, Igarashi Y, Yang L, et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 1997;121:969-73.
18. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000;349:385-402.
19. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 2004;92:913-22.
20. Lin CI, Chen CN, Lin PW, Lee H. Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochem Biophys Res Commun 2007;355:895-901.
21. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 2001;8:71-88.
22. Van Putte BP, Kesecioglu J, Hendriks JM, et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care 2005;9:R1-8.
23. De Greef KE, Ysebaert DK, Ghielli M, et al. Neutrophils and acute ischemia-reperfusion injury. J Nephrol 1998;11:110-22.
24. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006;27:337-49.
25. Oto T, Griffiths AP, Rosenfeldt F, Levvey BJ, Williams TJ, Snell GI. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006;82:1842-8.
26. Bostanci K, Toker A, Bayrak Y, et al. Dose-related effects of theophylline added to modified Euro-Collins solution used for hypothermic preservation of lung. J Cardiothorac Vasc Anesth 2003;17:721-4.
27. Jayle C, Corbi P, Eugene M, et al. Beneficial effect of polyethylene glycol in lung preservation: early evaluation by proton nuclear magnetic resonance spectroscopy. Ann Thorac Surg 2003;76:896-902.
28. Kuwaki K, Komatsu K, Sohma H, Abe T. Lazaroid U74389G ameliorates ischemia-reperfusion injury in the rat lung transplant model. Ann Thorac Cardiovasc Surg 1999;5:11-7.
29. Vainikka T, Heikkila L, Kukkonen S, Toivonen H, Verkkala K, Mattila S. Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation. Eur Surg Res 1999;31:429-36.
30. Kukkonen S, Heikkila L, Verkkala K, Mattila S, Toivonen H. Pulmonary vasodilatory properties of prostaglandin E1 are blunted after experimental single lung transplantation. J Heart Lung Transplant 1995;14:280-8.
31. Chiang CH, Hsu K, Yan HC, Harn HJ, Chang DM. PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury. J Appl Physiol 1997;83:583-90.
32. Sanna MG, Liao J, Jo E, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004;279:13839-48.
33. Goetzl EJ, Wang W, McGiffert C, Huang MC, Graler MH. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem 2004;92:1104-14.
34. Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 2005;19:1646-56.
35. Moreno L, Dudek S, Garcia JGN. Sphingolipids and lung vascular barrier regulation. In: Hirabayashi I, Merrill A, editors. Sphingolipid biology, Vol. 1, 1st ed. Tokyo, Japan: Springer; 2006.
36. Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000;15:1562-74.
37. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med 1985;26:72-6.
38. Vessey DA, Kelley M, Li L, et al. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 2006;12:BR318-24.
39. Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006;114:1403-9.
40. Awad AS, Ye H, Huang L, et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006;290:F1516-24.
41. Lee C, Xu DZ, Feketeova E, et al. Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. J Trauma 2004;57:955-60.
42. Okazaki M, Kreisel F, Richardson SB, et al. Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant 2007;7:751-8.